Rosen Law Firm Investigates TruBridge Securities Claims
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 38 minutes ago
0mins
Should l Buy TBRG?
Source: PRnewswire
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims on behalf of TruBridge, Inc. (NASDAQ:TBRG) shareholders due to allegations of materially misleading business information, which may result in investor losses.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to submit the Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and reliability.
- Class Action Preparation: Rosen Law Firm is preparing a class action to seek recovery of investor losses, allowing investors to participate without upfront costs, demonstrating the firm's commitment to protecting investor rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TBRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TBRG
Wall Street analysts forecast TBRG stock price to fall
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 25.830
Low
21.00
Averages
22.00
High
23.00
Current: 25.830
Low
21.00
Averages
22.00
High
23.00
About TBRG
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Rosen Law Firm Investigates TruBridge Securities Claims
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims on behalf of TruBridge, Inc. (NASDAQ:TBRG) shareholders due to allegations of materially misleading business information, which may result in investor losses.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to submit the Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and reliability.
- Class Action Preparation: Rosen Law Firm is preparing a class action to seek recovery of investor losses, allowing investors to participate without upfront costs, demonstrating the firm's commitment to protecting investor rights.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, which has negatively impacted investor confidence.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to submit its Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, potentially exposing investors to losses.
- Stock Price Decline: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial health and accuracy of its reporting.
- Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for affected investors, with no upfront costs required, which may encourage more impacted investors to join the lawsuit.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) regarding its sale to Angelini Pharma S.p.A. for $31.50 per share, as potential violations of shareholder rights may exist, prompting shareholders to understand their rights and options.
- Transaction Details: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, with Halper Sadeh LLC urging shareholders to be aware of potential legal rights and compensation opportunities.
- Merger Impact: Following the proposed transaction, Modiv Industrial, Inc. (NYSE:MDV) shareholders are expected to own approximately 11% of the combined company, and Halper Sadeh LLC may seek increased compensation for shareholders.
- Legal Support: Halper Sadeh LLC represents investors globally, focusing on legal remedies for securities fraud and corporate misconduct, emphasizing its successful track record in implementing corporate reforms and recovering funds for defrauded investors.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ:TBRG) for allegedly issuing materially misleading business information, which may entitle investors to compensation without any out-of-pocket fees.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to file the Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, which could undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns over the company's financial transparency and potential investor losses.
- Legal Action Preparation: Rosen Law Firm is preparing a class action to recover investor losses, emphasizing the importance of selecting qualified counsel with a successful track record to effectively protect investors' rights.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating Organon & Co. (NYSE:OGN) regarding its sale to Sun Pharmaceutical Industries Limited at $14.00 per share, which may involve breaches of shareholder rights.
- Shareholder Rights Protection: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights and options to ensure fair treatment.
- Merger Transaction Review: The merger between Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) and Korsana Biosciences, Inc. is expected to result in Cyclerion shareholders owning approximately 1.5% of the combined company, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
- Investor Protection Actions: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, highlighting its crucial role in safeguarding shareholder interests.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) for possibly issuing materially misleading business information, highlighting significant risks to corporate governance and transparency.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely submit its Annual Report for the fiscal year 2025 due to the identification of errors in previously issued financial statements, which may lead to decreased investor confidence and impact stock prices.
- Stock Price Decline: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial health and stability.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket fees, which may attract more affected investors and increase the legal risks faced by the company.
See More
Rosen Law Firm Investigates TruBridge Securities Claims
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims on behalf of TruBridge, Inc. (NASDAQ:TBRG) shareholders due to allegations of materially misleading business information, which may result in investor losses.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to submit the Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and reliability.
- Class Action Preparation: Rosen Law Firm is preparing a class action to seek recovery of investor losses, allowing investors to participate without upfront costs, demonstrating the firm's commitment to protecting investor rights.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, which has negatively impacted investor confidence.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to submit its Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, potentially exposing investors to losses.
- Stock Price Decline: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial health and accuracy of its reporting.
- Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for affected investors, with no upfront costs required, which may encourage more impacted investors to join the lawsuit.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) regarding its sale to Angelini Pharma S.p.A. for $31.50 per share, as potential violations of shareholder rights may exist, prompting shareholders to understand their rights and options.
- Transaction Details: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, with Halper Sadeh LLC urging shareholders to be aware of potential legal rights and compensation opportunities.
- Merger Impact: Following the proposed transaction, Modiv Industrial, Inc. (NYSE:MDV) shareholders are expected to own approximately 11% of the combined company, and Halper Sadeh LLC may seek increased compensation for shareholders.
- Legal Support: Halper Sadeh LLC represents investors globally, focusing on legal remedies for securities fraud and corporate misconduct, emphasizing its successful track record in implementing corporate reforms and recovering funds for defrauded investors.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ:TBRG) for allegedly issuing materially misleading business information, which may entitle investors to compensation without any out-of-pocket fees.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to file the Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, which could undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns over the company's financial transparency and potential investor losses.
- Legal Action Preparation: Rosen Law Firm is preparing a class action to recover investor losses, emphasizing the importance of selecting qualified counsel with a successful track record to effectively protect investors' rights.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating Organon & Co. (NYSE:OGN) regarding its sale to Sun Pharmaceutical Industries Limited at $14.00 per share, which may involve breaches of shareholder rights.
- Shareholder Rights Protection: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights and options to ensure fair treatment.
- Merger Transaction Review: The merger between Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) and Korsana Biosciences, Inc. is expected to result in Cyclerion shareholders owning approximately 1.5% of the combined company, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
- Investor Protection Actions: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, highlighting its crucial role in safeguarding shareholder interests.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) for possibly issuing materially misleading business information, highlighting significant risks to corporate governance and transparency.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely submit its Annual Report for the fiscal year 2025 due to the identification of errors in previously issued financial statements, which may lead to decreased investor confidence and impact stock prices.
- Stock Price Decline: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial health and stability.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket fees, which may attract more affected investors and increase the legal risks faced by the company.
See More
